Gemmer Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-780
| Closed | -$66K | – | 1329 |
|
|
2020
Q1 | $66K | Sell |
780
-20
| -3% | -$1.69K | 0.02% | 146 |
|
|
2019
Q4 | $68K | Sell |
800
-2
| -0.2% | -$170 | 0.02% | 164 |
|
|
2019
Q3 | $54K | Buy |
802
+2
| +0.3% | +$135 | 0.01% | 184 |
|
|
2019
Q2 | $69K | Hold |
800
| – | – | 0.02% | 154 |
|
|
2019
Q1 | $71K | Hold |
800
| – | – | 0.02% | 150 |
|
|
2018
Q4 | $68K | Hold |
800
| – | – | 0.02% | 142 |
|
|
2018
Q3 | $78K | Sell |
800
-200
| -20% | -$19.5K | 0.02% | 136 |
|
|
2018
Q2 | $94K | Sell |
1,000
-700
| -41% | -$65.8K | 0.03% | 120 |
|
|
2018
Q1 | $138K | Sell |
1,700
-500
| -23% | -$40.6K | 0.05% | 100 |
|
|
2017
Q4 | $196K | Hold |
2,200
| – | – | 0.07% | 82 |
|
|
2017
Q3 | $205K | Hold |
2,200
| – | – | 0.08% | 80 |
|
|
2017
Q2 | $200K | Sell |
2,200
-550
| -20% | -$50K | 0.08% | 82 |
|
|
2017
Q1 | $241K | Sell |
2,750
-1,600
| -37% | -$140K | 0.11% | 69 |
|
|
2016
Q4 | $360K | Buy |
4,350
+3,600
| +480% | +$298K | 0.18% | 51 |
|
|
2016
Q3 | $69K | Buy |
+750
| New | +$69K | 0.04% | 129 |
|